| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30014102 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS30014108 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS30047831 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS30047832 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS30047833 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS30017454 | HIV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS20032025 | HPV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS20022411 | HPV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
| TVIS20020749 | HPV | ENSG00000105397.16 | protein_coding | TYK2 | Yes | No | 7297 | P29597 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TYK2 |
|---|---|
| DrugBank ID | DB08877 |
| Drug Name | Ruxolitinib |
| Target ID | BE0004146 |
| UniProt ID | P29597 |
| Regulation Type | inhibitor |
| PubMed IDs | 21919691; 23061804 |
| Citations | Ostojic A, Vrhovac R, Verstovsek S: Ruxolitinib: a new JAK1/2 inhibitor that offers promising options for treatment of myelofibrosis. Future Oncol. 2011 Sep;7(9):1035-43. doi: 10.2217/fon.11.81.@@Yang LP, Keating GM: Ruxolitinib: in the treatment of myelofibrosis. Drugs. 2012 Nov 12;72(16):2117-27. doi: 10.2165/11209340-000000000-00000. |
| Groups | Approved |
| Direct Classification | Pyrrolo[2,3-d]pyrimidines |
| SMILES | N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1 |
| Pathways | |
| PharmGKB | PA166123386 |
| ChEMBL | CHEMBL1789941 |
